Shahrokh F. Shariat
Shahrokh F. Shariat is an Associate Professor of urology and brings with him a reputation for cutting-edge research and practices in the field of urologic oncology. Dr. Shariat has been recognized year after year as one of America’s Top Urologists by the Consumer Research Council of America. He has published more than 350 research papers and a dozen book chapters, is the holder of five patents stemming from his research into prostate cancers and bladder cancers, and is the recipient of several national and international rewards. Dr. Shariat is a sought-after speaker and visiting professor. He is currently spearheading several collaborative multicenter groups and prospective clinical trials. He has mentored many students, residents, and fellows. Dr. Shariat has had continuous competitive funding. He is a member of various academic societies, and he is a journal, meeting abstract, and grant reviewer for numerous national and international organizations. He is an editorial board member of various journals including European Urology, BJU International, Immunotherapy, Oncology Reports, and Journal of Men's Health. His research focuses on urologic oncology, molecular mechanisms, markers, early detection, natural history, treatment, translational, and outcomes research. He has coauthored over 350 peer-review articles and a dozen book chapters. Dr. Shariat completed his undergraduate training and medical school in Vienna, Austria. After graduating with highest honors, he did two postdoctoral fellowships in molecular biology (with focus on gene and vaccine therapy) and urologic oncology (with focus on outcomes research and biomarkers) at Baylor College of Medicine, Houston, Tex, USA. He held faculty positions at Baylor and University of Texas Southwestern Medical Center, Dallas, Tex, USA. He completed his residency at the University of Texas Southwestern in Dallas and a fellowship at Memorial Sloan-Kettering Cancer Center.
Biography Updated on 12 January 2011